DENTAL TREATMENT IN A PATIENT WITH FUKUYAMA TYPE MUSCULAR DYSTROPHY UNDER TOTAL INTRAVENOUS ANESTHESIA USING PROPOFOL

진달래; Shin Teo Jeon; Hong-Keun Hyun; Kim, Young J; Kim, JungWook; Sang-Hoon Lee; 김종철; Jang, KiTaeg

Muscular dystrophy is a genetically heterogeneous group of disorders characterized by progressive muscle weakness of variable distribution and severity. Fukuyama type congenital muscular dystrophy (FCMD) is an unusual form of muscular dystrophy with autosomal recessive inheritance and is clinically characterized by an early age of onset, severe central nervous system involvement, facial muscle weakness, and multiple joint contractures. Muscular dystrophy is susceptible to perioperative respiratory, cardiac and other complications. Patients with FCMD have upper airway muscle weakness, therefore general anesthesia is preferred to sedation regarding maintaining the airway when treating these patients. The development of malignant hyperthermia in general anesthesia for patients with muscular dystrophy is a concern. Total intravenous anesthesia should be used instead of inhaled anesthetics because of the risk of malignant hyperthermia. A 3-year-9-month old, 13kg girl with Fukuyama type congenital muscular dystrophy was scheduled for dental treatment under general anesthesia. She had multiple caries and 14 primary teeth needed caries treatment. Prior to general anesthesia, oral premedication with 9 mg midazolam was given. General anesthesia was induced and maintained with target controlled infusion of propofol 3~3.5 μg/mL. The patient with progressive muscular dystrophy was successfully treated under total intravenous anesthesia with a target controlled infusion of propofol. There were no complications related to anesthesia and dental treatment during or after the operation. This case suggests that target controlled infusion of propofol is a safe and appropriate anesthetic technique in FCMD patients for dental treatment.

Citation status

KCI Citation Counts (0)
REFERENCES (25)
열림/닫힘 버튼
* 2021년 이후 발행 논문의 참고문헌은 현재 구축 중입니다.

[journal] Fukuyama Y / 1960 / A peculiar form of congenital progressive muscular dystrophy / Paediatr Univ Tokyo 4 : 5~8

[journal] T. Toda / 2000 / The Fukuyama congenital muscular dystrophy story / Neuromuscular Disorders 10 : 153~159

[book] Osawa M / 1997 / Fukuyama type congenital muscular dystrophy, In Congenital Muscular Dystrophies / Elsevier Science : 31~68

[web] National Center for Biotechnology Information (NCBI) / Gene Reviews by title: Fukuyama Congenital Muscular Dystrophy / http://www.ncbi.nlm.nih.gov/books/NBK1206/

[journal] Kiichi Arahata / 2000 / Muscular dystrophy / Neuropathology 20 : 34~41

[journal] Toda T / 2000 / Fukuyama-type congenital muscular dystrophy / Rinsho Shinkeigaku 40 : 1297~1299

[journal] K. Kobayashi / 1998 / An ancient retrotransposal insertion causes Fukuyamatype congenital muscular dystrophy / Nature 394 : 388~392

[journal] Fumiaki Saito / 2011 / Fukuyamatype congenital muscular dystrophy and defective glycosylation of α-dystroglycan / Skeletal Muscle 1 : 22~

[journal] Kawaai / 2005 / Continuous infusion propofol general anesthesia for dental treatment in patients with progressive muscular dystrophy / Anesth Prog 54 : 12~16

[journal] Gurnaney H / 2009 / Malignant hyperthermia and muscular dystrophies / Anesth Analg 109 : 1043~1048

[journal] Gerald V / 1999 / Inhalation anesthetics and Duchenne’s muscular dystrophy / Can J Anaesth 46 : 525~528

[journal] Chalkiadis GA / 1990 / Cardiac arrest after isoflurane anesthesia in a patient with Duchenne’s muscular dystrophy / Anaesthesia 45 : 22~25

[journal] Sethna NF / 1986 / Cardiac arrest following inhalation induction of anaesthesia in child with Duchenne’s muscular dystrophy / Can Anaesth Soc J 33 : 799~802

[journal] Larsen UT / 1989 / Complications during anaesthesia in patients with Duchenne’s muscular dystrophy (a retrospective study) / Can J Anaesth 36 : 418~422

[journal] Josie K. / 2001 / MacIntyre : Malignant hyperthermia / Phys Ther 81 : 945~951

[journal] T. Toda / 1993 / Localization of a gene for Fukuyama type congenital musculardystrophy to chromosome 9q31-33 / Nature Genet 5 : 283~286

[journal] Heiman-Patterson TD / 1993 / Neuroleptic malignant syndrome and malignant hyperthermia: important issues for the medical consultant / Med Clin North Am 77 : 477~492

[journal] Halsall PJ / 2003 / Malignant hyperthermia / Continuing Education in Anaethesia, Critical Care and Pain 3 : 5~9

[journal] Poels PJE / 1993 / Rhabdomyolysis: a review of the literature / Clin Neurol Neurosurg 95 : 175~192

[journal] Enzmann NR / 1998 / Malignant hyperthermia : effects of sarcoplasmic reticulum Ca2+ pump inhibition / Muscle Nerve 21 : 361~366

[journal] Yemen TA / 2006 / Muscular dystrophy, anesthesia and the safety of inhalational agents revisited; again / Paediatr Anaesth 16 : 105~108

[journal] Fruen BR / 1995 / Effects of propofol on Ca2+ regulation by malignant hyperthermia- susceptible muscle membranes / Anesthesiology 82 : 1274~1282

[web] Wikipedia / Propofol / http://en.wikipedia.org/wiki/Propofol

[journal] Kim DW / 2003 / Target controlled infusion / J Korean Med Assoc 46 : 454~460

[journal] Wilson G / 2010 / Target controlled infusion anaesthesia in children / S Afr J Anaesthesiol Analg 16 : 124~126

KJC Korea
Journal Central

Statistics

Tools

Sharing

Issue List

Citation status